1 |
Simone JV. Childhood leukemia-successes and challenges for survivors. N Engl J Med 2003;349:627-8
DOI
ScienceOn
|
2 |
Beutler E. The treatment of acute leukemia: past, present, and future. Leukemia 2001;15:658-61
DOI
|
3 |
Farber S, Diamond LK, Mercer RD. Temporary remissions in acute leukemia produced by folic acid antagonist, 4-aminopteroylglutamic acid (aminopterin). N Engl J Med 1948;238:787
|
4 |
Arico M, Valsecchi MG, Camitta B, Schrappe M, Chessells J, Baruchel A, et al. Outcome of treatment in children with Philadelphia chromosome-positive acute lymphoblastic leukemia. N Engl J Med 2000;342:998-1006
DOI
ScienceOn
|
5 |
Shin HY, Kang HJ, Park ES, Choi HS, Ahn HS, Kim SY, et al. Recombinant urate oxidase (Rasburicase) for the treatment of hyperuricemia in pediatric patients with hematologic malignancies: Results of a compassionate prospective multicenter study in Korea. Pediatr Blood Cancer 2006;46:439-45
DOI
ScienceOn
|
6 |
Uckun FM, Nachman JB, Sather HN, Sensel MG, Kraft P, Steinherz PG, et al. Clinical significance of Philadelphia chromosome positive pediatric acute lymphoblastic leukemia in the context of contemporary intensive therapies: a report from the Children's Cancer Group. Cancer 1998;83:2030-9
DOI
ScienceOn
|
7 |
Hilden JM, Kersey JH. The MLL (11q23) and AF-4 (4q21) genes disrupted in t(4;11) acute leukemia: molecular and clinical studies. Leuk Lymphoma 1994;14:189-95
DOI
ScienceOn
|
8 |
Silverman LB, Sallan SE. Newly diagnosed childhood acute lymphoblastic leukemia: update on prognostic factors and treatment. Curr Opin Hematol 2003;10:290-6
DOI
ScienceOn
|
9 |
Gaynon PS, Trigg ME, Heerema NA, Sensel MG, Sather HN, Hammond GD, et al. Children's Cancer Group trials in childhood acute lymphoblastic leukemia: 1983-1995. Leukemia 2000;14:2223-33
|
10 |
Deangelo DJ. The treatment of adolescents and young adults with acute lymphoblastic leukemia. Hematology (Am Soc Hematol Educ Program) 2005;:123-30
DOI
ScienceOn
|
11 |
Smith M, Arthur D, Camitta B, Carroll AJ, Crist W, Gaynon P, et. al. Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia. J Clin Oncol 1996;14:18-24
DOI
|
12 |
Singh TP. Clinical trials of newly developed anti-cancer agents in children with acute leukemia. Contemp Clin Trials 2006;27:493
DOI
ScienceOn
|
13 |
Woodhouse JR, Ferry DR. The genetic basis of resistance to cancer chemotherapy. Ann Med 1995;27:157-67
DOI
|
14 |
Frei E 3rd. Acute leukemia in children. Model for the development of scientific methodology for clinical therapeutic research in cancer. Cancer 1984;53:2013-25
DOI
ScienceOn
|
15 |
Pui CH, Jeha S. New therapeutic strategies for the treatment of acute lymphoblastic leukaemia. Nat Rev Drug Discov 2007;6:149-65
DOI
ScienceOn
|
16 |
Pui CH, Schrappe M, Ribeiro RC, Niemeyer CM. Childhood and adolescent lymphoid and myeloid leukemia. Hematology (Am Soc Hematol Educ Program) 2004;:118-45
DOI
ScienceOn
|
17 |
Kersey JH. Fifty years of studies of the biology and therapy of childhood leukemia. Blood 1997;90:4243-51
|
18 |
Choi J, Hwang YK, Sung KW, Lee SH, Yoo KH, Jung HL, et al. Expression of Livin, an antiapoptotic protein, is an independent favorable prognostic factor in childhood acute lymphoblastic leukemia. Blood 2007;109:471-7
DOI
ScienceOn
|
19 |
Marshall GM, Haber M, Kwan E, Zhu L, Ferrara D, Xue C, et al. Importance of minimal residual disease testing during the second year of therapy for children with acute lymphoblastic leukemia. J Clin Oncol 2003;21:704-9
DOI
ScienceOn
|
20 |
Pui CH, Relling MV, Evans WE. Role of pharmacogenomics and pharmacodynamics in the treatment of acute lymphoblastic leukaemia. Best Pract Res Clin Haematol 2002;15:741-56
DOI
ScienceOn
|
21 |
Childhood ALL Collaborative Group. Duration and intensity of maintenance chemotherapy in acute lymphoblastic leukaemia: overview of 42 trials involving 12,000 randomised children. Lancet 1996;347:1783-8
DOI
ScienceOn
|
22 |
Yeoh EJ, Ross ME, Shurtleff SA, Williams WK, Patel D, Mahfouz R, et al. Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling. Cancer Cell 2002;1:133- 43
DOI
ScienceOn
|